[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371036-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371036-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-comparative-metabolomics-study-of-multiple-urological-diseases-by-highly-sensitive-dansylation-isotope-labeling-lc-ms","A Comparative Metabolomics Study of Multiple Urological Diseases by Highly Sensitive Dansylation Isotope Labeling LC-MS","","Urine analysis is a non-invasive testing approach that, when combined with metabolomics, enables detection of small-molecule metabolites as biomarkers reflecting abnormal metabolic activity in the urinary tract, including drug interactions, toxicity, and disease states. Current comparative analyses across multiple urinary tract pathologies remain limited. Here, 12C2/13C2 chemical dansylation labeling is applied to profile eight urological conditions against normal controls, producing metabolite panels to distinguish groups and identify dysregulated and stable metabolites.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-comparative-metabolomics-study-of-multiple-urological-diseases-by-highly-sensitive-dansylation-isotope-labeling-lc-ms/371036/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-comparative-metabolomics-study-of-multiple-urological-diseases-by-highly-sensitive-dansylation-isotope-labeling-lc-ms/371036.png","ImageObject",300,407,{"name":42,"@type":43},"PakDamar76","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of the study?","Question",{"text":63,"@type":64},"To compare urinary metabolomic profiles across multiple urological conditions using highly sensitive dansylation isotope labeling LC-MS and identify metabolites that differentiate diseases.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were urine metabolites labeled and analyzed?",{"text":68,"@type":64},"Urinary amine/phenol metabolome profiles were generated using 12C2/13C2 chemical dansylation labeling, followed by LC–MS/MS analysis of metabolite peak pairs.",{"name":70,"@type":61,"acceptedAnswer":71},"What kinds of metabolites were identified as useful markers?",{"text":72,"@type":64},"The study reports dysregulated metabolites distinguishing patients with versus without cancer, metabolites differing between benign prostatic hyperplasia and prostate cancer, and a set of identified metabolites showing substantial stability across urological conditions.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371036,1790224507,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893057,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nA Comparative Metabolomics Study of Multiple Urological Diseases by Highly Sensitive Dansylation Isotope Labeling LC-MS  \nWei-Hsuan Wang 1,2,†, Ya-Ju Hsieh 3,†, Chien-Lun Chen 4, *, Ying-Hsu Chang 1,4,5, Yi-Huai Tsai 3, Chih-Hsiang Chang 6, Liang Li 7, Wei-Ju Tu 8, Jau-Song Yu 3,8 and Yi-Ting Chen 3,6,8,9, *  \nAcademic Editor: Ligia Petrica  \nReceived: 11 August 2025  \nRevised: 14 November 2025  \nAccepted: 19 November 2025  \nPublished: 24 November 2025  \nCitation: Wang, W.-H.; Hsieh, Y.-J.; Chen, C.-L.; Chang, Y.-H.; Tsai, Y.-H.; Chang, C.-H.; Li, L.; Tu, W.-J.; Yu, J.-S.; Chen, Y.-T. A Comparative Metabolomics Study of Multiple Urological Diseases by Highly Sensitive Dansylation Isotope Labeling LC-MS. Int. J. Mol. Sci. 2025, 26, 11353. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms262311353  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 College of Medicine, Chang Gung University, Taoyuan 333, Taiwan; [will00613@yahoo.com.tw](will00613@yahoo.com.tw) (W.-H.W.); [changyinghsu@gmail.com](changyinghsu@gmail.com) (Y.-H.C.)  \n2 Medical Education Department, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan  \n3 Molecular Medicine Research Center, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan; [hsiehyaju@mail.cgu.edu.tw](hsiehyaju@mail.cgu.edu.tw) (Y.-J.H.); [kopa92414@gmail.com](kopa92414@gmail.com) (Y.-H.T.); [yusong@mail.cgu.edu.tw](yusong@mail.cgu.edu.tw) (J.-S.Y.)  \n4 Department of Urology, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan  \n5 Department of Urology, New Taipei Municipal TuCheng Hospital, New Taipei 236, Taiwan  \n6 Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan; [franwisandsun@gmail.com](franwisandsun@gmail.com)  \n7 Department of Chemistry, University of Alberta, Edmonton, AB T6G2G2, Canada; [liang.li@ualberta.ca](liang.li@ualberta.ca)  \n8 Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan; [imtuweiju@gmail.com](imtuweiju@gmail.com)  \n9 Department of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan  \n* Correspondence: [clc2679@cgmh.org.tw](clc2679@cgmh.org.tw) (C.-L.C.); [ytchen@mail.cgu.edu.tw](ytchen@mail.cgu.edu.tw) (Y.-T.C.)† These authors contributed equally to this work.  \nAbstract  \nUrine analysis is a straightforward, non-invasive testing method that, when integrated with metabolomics, shows great potential for detecting small-molecule metabolites as biomarkers of abnormal metabolic activity in the urinary tract, including drug interactions, toxicity, and diseases. However, integrated and comparative analyses of multiple urinary tract pathologies are currently limited. In this study, 12C2/13C2-chemical dansylation labeling was used to explore the urinary amine/phenol-metabolome profiles of eight urological conditions compared with normal profiles. We obtained ten samples for each condition (disease and normal) from a total of 90 participants, pooling them as representative samples, and constructed metabolite panels to differentiate various urological conditions. We discovered nine metabolites that were dysregulated between urine samples from patients with and without cancer. Another seven metabolites were differentially expressed between the benign prostatic hyperplasia group and the prostate cancer group. Among 1854 peak pairs of metabolites in an amine/phenol submetabolome analyzed by dansyl chloride derivatization coupled with LC–MS/MS, 1747 (94.2%) were detectable in urine specimens from all nine groups. Notably, 18 identified metabolites showed substantial stability across all urological conditions. Gi","cbCainfnoSDFUVDu","https://ap.wps.com/l/cbCainfnoSDFUVDu","pdf",2624424,17,"English","# Abstract\n# Introduction","[{\"question\":\"What is the main goal of the study?\",\"answer\":\"To compare urinary metabolomic profiles across multiple urological conditions using highly sensitive dansylation isotope labeling LC-MS and identify metabolites that differentiate diseases.\"},{\"question\":\"How were urine metabolites labeled and analyzed?\",\"answer\":\"Urinary amine/phenol metabolome profiles were generated using 12C2/13C2 chemical dansylation labeling, followed by LC–MS/MS analysis of metabolite peak pairs.\"},{\"question\":\"What kinds of metabolites were identified as useful markers?\",\"answer\":\"The study reports dysregulated metabolites distinguishing patients with versus without cancer, metabolites differing between benign prostatic hyperplasia and prostate cancer, and a set of identified metabolites showing substantial stability across urological conditions.\"}]","A Comparative Metabolomics Study of Multiple Urological Diseases by Highly Sensitive Dansylation Isotope Labeling LC-MS | PDF",1790191089,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/66a2ebbada3e14ac652669e8554bf2f0.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b29ed0fd13cfddf1dd94d951f6555ee0.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d142759e7d234f1345eba978225b41d.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc8c79d8a6f3946bcaa719bc48802482.webp",980,1385]